Obesity, Gut Microbiota, and Metabolome: From Pathophysiology to Nutritional Interventions.
Zivana PuljizMarko KumrićJosip VrdoljakDinko MartinovicTina Ticinovic KurirMarin Ozren KrnicHrvoje UrlicZeljko PuljizJurica ZuckoPetra DumanicIvana MikolasevicJosko BozicPublished in: Nutrients (2023)
Obesity is a disorder identified by an inappropriate increase in weight in relation to height and is considered by many international health institutions to be a major pandemic of the 21st century. The gut microbial ecosystem impacts obesity in multiple ways that yield downstream metabolic consequences, such as affecting systemic inflammation, immune response, and energy harvest, but also the gut-host interface. Metabolomics, a systematized study of low-molecular-weight molecules that take part in metabolic pathways, represents a serviceable method for elucidation of the crosstalk between hosts' metabolism and gut microbiota. In the present review, we confer about clinical and preclinical studies exploring the association of obesity and related metabolic disorders with various gut microbiome profiles, and the effects of several dietary interventions on gut microbiome composition and the metabolome. It is well established that various nutritional interventions may serve as an efficient therapeutic approach to support weight loss in obese individuals, yet no agreement exists in regard to the most effective dietary protocol, both in the short and long term. However, metabolite profiling and the gut microbiota composition might represent an opportunity to methodically establish predictors for obesity control that are relatively simple to measure in comparison to traditional approaches, and it may also present a tool to determine the optimal nutritional intervention to ameliorate obesity in an individual. Nevertheless, a lack of adequately powered randomized trials impedes the application of observations to clinical practice.
Keyphrases
- weight loss
- bariatric surgery
- metabolic syndrome
- insulin resistance
- weight gain
- type diabetes
- high fat diet induced
- roux en y gastric bypass
- gastric bypass
- physical activity
- randomized controlled trial
- public health
- sars cov
- clinical practice
- mental health
- body mass index
- microbial community
- mass spectrometry
- glycemic control
- climate change
- coronavirus disease
- risk assessment
- mesenchymal stem cells
- dendritic cells
- toll like receptor
- cell therapy
- drug induced
- human health